T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Methode Electronics
MEI
$602M
| $50.1M | 0.01% |
1,462,450
+5,660
| +0.4% | +$166K |
|
|
FCS
777
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $50M | 0.01% |
2,517,327
-168,483
| -6% | -$3.35M |
|
778
Liberty Broadband Class C
LBRDK
$5.07B
| $49.7M | 0.01% |
828,001
+528,277
| +176% | +$30.8M |
|
|
ESGR
779
DELISTED
Enstar Group
ESGR
| $49.6M | 0.01% |
306,494
+1,212
| +0.4% | +$191K |
|
780
Welltower
WELL
$166B
| $49.6M | 0.01% |
650,920
+400
| +0.1% | +$28.4K |
|
|
SONC
781
DELISTED
Sonic Corp
SONC
| $49.5M | 0.01% |
1,831,027
-179,530
| -9% | -$5.74M |
|
|
PIR
782
DELISTED
Pier 1 Imports, Inc.
PIR
| $49.5M | 0.01% |
481,082
-186,332
| -28% | -$22.5M |
|
783
Reliance Steel & Aluminium
RS
$21.8B
| $49.4M | 0.01% |
642,973
-806
| -0.1% | -$59.1K |
|
784
Tyler Technologies
TYL
$13B
| $49.4M | 0.01% |
296,524
+8,384
| +3% | +$1.24M |
|
|
VIVO
785
DELISTED
Meridian Bioscience Inc
VIVO
| $49.3M | 0.01% |
2,526,495
-18,080
| -0.7% | -$355K |
|
|
STJ
786
DELISTED
St Jude Medical
STJ
| $48.9M | 0.01% |
626,374
-7,470
| -1% | -$533K |
|
|
CRAY
787
DELISTED
Cray, Inc.
CRAY
| $48.8M | 0.01% |
1,629,847
+142,070
| +10% | +$4.98M |
|
788
Advanced Energy
AEIS
$13.5B
| $48.8M | 0.01% |
1,284,280
-314,330
| -20% | -$11.2M |
|
789
Domino's
DPZ
$11.7B
| $48.7M | 0.01% |
370,955
-6,190
| -2% | -$787K |
|
|
MDCO
790
DELISTED
Medicines Co
MDCO
| $48.7M | 0.01% |
1,448,500
+1,660
| +0.1% | +$58.5K |
|
791
FTI Consulting
FCN
$4.22B
| $48.5M | 0.01% |
1,192,135
-23,800
| -2% | -$942K |
|
792
SLM Corp
SLM
$5.26B
| $48.4M | 0.01% |
7,839,118
+7,658,740
| +4,246% | +$49.9M |
|
793
Moody's
MCO
$82.8B
| $48.4M | 0.01% |
516,416
+3,800
| +0.7% | +$367K |
|
|
NGD
794
DELISTED
New Gold Inc
NGD
| $48.4M | 0.01% |
11,114,056
-5,159,234
| -32% | -$21.8M |
|
795
Hope Bancorp
HOPE
$1.83B
| $48.3M | 0.01% |
3,236,480
+621,600
| +24% | +$9.63M |
|
796
Agnico Eagle Mines
AEM
$93.8B
| $48.2M | 0.01% |
900,529
-1,017,160
| -53% | -$46.2M |
|
|
COBZ
797
DELISTED
CoBiz Financial,Inc
COBZ
| $48M | 0.01% |
4,105,197
+743,534
| +22% | +$8.94M |
|
798
QuidelOrtho
QDEL
$1.02B
| $48M | 0.01% |
2,688,716
+60,464
| +2% | +$1.05M |
|
799
Wintrust Financial
WTFC
$11B
| $47.8M | 0.01% |
936,381
-15,669
| -2% | -$784K |
|
|
CCMP
800
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $47.3M | 0.01% |
1,117,636
-56,590
| -5% | -$2.37M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.